OppenheimerFunds’s AMN Healthcare AMN Stock Holding History

OppenheimerFunds’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$6.87M	Sell	145,799 -344,144	-70%	-$19.1M	0.01%	719
2018 Q4	$27.8M	Buy	489,943 +42,114	+9%	+$2.36M	0.04%	427
2018 Q3	$24.5M	Buy	447,829 +155,286	+53%	+$8.89M	0.03%	531
2018 Q2	$17.1M	Buy	292,543 +271,949	+1,321%	+$16.2M	0.02%	617
2018 Q1	$1.17M	Sell	20,594 -6,555	-24%	-$356K	﹤0.01%	1007
2017 Q4	$1.34M	Sell	27,149 -7,657	-22%	-$349K	﹤0.01%	1056
2017 Q3	$1.59M	Sell	34,806 -5,691	-14%	-$217K	﹤0.01%	1011
2017 Q2	$1.58M	Buy	40,497 +6,095	+18%	+$234K	﹤0.01%	1014
2017 Q1	$1.4M	Buy	34,402 +4,371	+15%	+$171K	﹤0.01%	1069
2016 Q4	$1.16M	Buy	30,031 +6,621	+28%	+$226K	﹤0.01%	1063
2016 Q3	$746K	Buy	23,410 +4,604	+24%	+$175K	﹤0.01%	1106
2016 Q2	$752K	Sell	18,806 -1,887	-9%	-$69.8K	﹤0.01%	1098
2016 Q1	$695K	Sell	20,693 -4,009	-16%	-$115K	﹤0.01%	1114
2015 Q4	$767K	Buy	+24,702	New	+$731K	﹤0.01%	1128

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

OppenheimerFunds's AMN Position: Q1 2019 in Review

OppenheimerFunds reduced its AMN Healthcare (AMN) stake by 70% in Q1 2019, selling an estimated $19.1M and leaving 145,799 shares worth $6.87M. The position accounts for 0.01% of the portfolio, ranked #719.

OppenheimerFunds first reported a position in AMN in Q4 2015 and has held it in 14 quarters since. The position peaked at $27.8M in Q4 2018. 311 funds tracked by Wall St. Rank hold AMN as of Q1 2019.

OppenheimerFunds held 145,799 shares of AMN Healthcare worth $6.87M as of Q1 2019.
OppenheimerFunds sold 344,144 AMN Healthcare shares in Q1 2019, an estimated $19.1M.
AMN Healthcare made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #719 holding.
OppenheimerFunds first reported a position in AMN Healthcare in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's AMN Healthcare position peaked at $27.8M in Q4 2018.
311 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.